206 related articles for article (PubMed ID: 22140552)
1. Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan.
Chen LH; Kuo WH; Tsai MH; Chen PC; Hsiao CK; Chuang EY; Chang LY; Hsieh FJ; Lai LC; Chang KJ
PLoS One; 2011; 6(11):e28222. PubMed ID: 22140552
[TBL] [Abstract][Full Text] [Related]
2. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
[TBL] [Abstract][Full Text] [Related]
3. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
Liu D
Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
[TBL] [Abstract][Full Text] [Related]
4. Combining gene signatures improves prediction of breast cancer survival.
Zhao X; Rødland EA; Sørlie T; Naume B; Langerød A; Frigessi A; Kristensen VN; Børresen-Dale AL; Lingjærde OC
PLoS One; 2011 Mar; 6(3):e17845. PubMed ID: 21423775
[TBL] [Abstract][Full Text] [Related]
5. Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population.
Huang CC; Tu SH; Lien HH; Jeng JY; Liu JS; Huang CS; Wu YY; Liu CY; Lai LC; Chuang EY
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S10. PubMed ID: 23046482
[TBL] [Abstract][Full Text] [Related]
6. Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.
Karn T; Pusztai L; Holtrich U; Iwamoto T; Shiang CY; Schmidt M; Müller V; Solbach C; Gaetje R; Hanker L; Ahr A; Liedtke C; Ruckhäberle E; Kaufmann M; Rody A
PLoS One; 2011; 6(12):e28403. PubMed ID: 22220191
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
[TBL] [Abstract][Full Text] [Related]
8. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
Liu D; Zhou K
Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling combined with functional analysis identify integrin beta1 (ITGB1) as a potential prognosis biomarker in triple negative breast cancer.
Klahan S; Huang WC; Chang CM; Wong HS; Huang CC; Wu MS; Lin YC; Lu HF; Hou MF; Chang WC
Pharmacol Res; 2016 Feb; 104():31-7. PubMed ID: 26675717
[TBL] [Abstract][Full Text] [Related]
10. Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma.
Mount DW; Putnam CW; Centouri SM; Manziello AM; Pandey R; Garland LL; Martinez JD
BMC Med Genomics; 2014 Jun; 7():33. PubMed ID: 24916928
[TBL] [Abstract][Full Text] [Related]
11. Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
Hu Y; Zou D
PLoS One; 2021; 16(12):e0260811. PubMed ID: 34965257
[TBL] [Abstract][Full Text] [Related]
12. GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.
Belyavskaya VA; Prudnikova TY; Domanitskaya NV; Litviakov NV; Maksimov VN; Cherdyntseva NV; Grigorieva EV
Gene; 2017 Sep; 628():224-229. PubMed ID: 28734894
[TBL] [Abstract][Full Text] [Related]
13. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
[TBL] [Abstract][Full Text] [Related]
14. High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
Chu QD; Panu L; Holm NT; Li BD; Johnson LW; Zhang S
J Surg Res; 2010 Apr; 159(2):689-95. PubMed ID: 19500800
[TBL] [Abstract][Full Text] [Related]
15. A 10-year follow-up of triple-negative breast cancer patients in Taiwan.
Lin C; Chien SY; Kuo SJ; Chen LS; Chen ST; Lai HW; Chang TW; Chen DR
Jpn J Clin Oncol; 2012 Mar; 42(3):161-7. PubMed ID: 22287721
[TBL] [Abstract][Full Text] [Related]
16. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
Zhong G; Lou W; Shen Q; Yu K; Zheng Y
Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
[TBL] [Abstract][Full Text] [Related]
17. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
18. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
19. Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study.
Zhou W; Pan H; Liang M; Xia K; Liang X; Xue J; Cheng L; Xue J; Chen S; Liu X; Ding Q; Ling L; Wang S
World J Surg Oncol; 2013 Oct; 11():248. PubMed ID: 24083544
[TBL] [Abstract][Full Text] [Related]
20. Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example.
Huang CS; Lin CH; Lu YS; Shen CY
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):300-3. PubMed ID: 20045728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]